MP20-19 ANTI-TUMOR EFFECT OF NANAOMYCIN K, A COMPOUND EXTRACTED FROM STREPTOMYCES, ON PROSTATE CANCER CELL LINES IN VITRO AND IN VIVO

Abstract

CONCLUSIONS: Together, these findings support the concept that the NO-CSF1Ri combination can act as a therapeutic agent that restores control over TME, which in turn could improve the outcomes of PCa patients.